切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2017, Vol. 11 ›› Issue (11) : 1902 -1905. doi: 10.3877/cma.j.issn.1674-0785.2017.11.008

所属专题: 总编推荐 文献

综述

黄褐斑激光治疗进展
余丽莎1, 曹莫2,(), 李辉正2, 姜江2, 程行健2, 张玟1, 平宇1   
  1. 1. 050051 石家庄,河北医科大学研究生院
    2. 050051 石家庄,河北医科大学第三医院整形外科
  • 收稿日期:2016-12-12 出版日期:2017-06-01
  • 通信作者: 曹莫

Progress in laser treatment of Chloasma

Lisha Yu1, Mo Cao2,(), Huizheng Li2, Jiang Jiang2, Xingjian Cheng2, Wen Zhang1, Yu Ping1   

  1. 1. Hebei Medical University, Shijiazhuang 050051, China
    2. The Third Hospital of Hebei Medical University, Shijiazhang 050051, China
  • Received:2016-12-12 Published:2017-06-01
  • Corresponding author: Mo Cao
  • About author:
    Corresponding author: Cao Mo, Email:
引用本文:

余丽莎, 曹莫, 李辉正, 姜江, 程行健, 张玟, 平宇. 黄褐斑激光治疗进展[J]. 中华临床医师杂志(电子版), 2017, 11(11): 1902-1905.

Lisha Yu, Mo Cao, Huizheng Li, Jiang Jiang, Xingjian Cheng, Wen Zhang, Yu Ping. Progress in laser treatment of Chloasma[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(11): 1902-1905.

黄褐斑是发生于面部,常呈对称分布的一种后天获得性色素过度沉着性疾病,中年女性好发,在很大程度上影响患者的生活质量,黄褐斑的发病受多种因素的影响,其中最主要的影响因素包括紫外线照射、内分泌失调、激素水平改变、遗传因素等,发病机制复杂,至今仍不是十分明确。治疗方法多种多样,尤以激光治疗效果明显,准确性及选择性较高,笔者着重对黄褐斑激光治疗的相关研究进行综述。

Chloasma is a disorder of symmetrical distribution of excessive facial melanosis, which usually occurs in middle-aged female and can affect their quality of life. The pathogenesis of chloasma is affected by many factors, including ultraviolet radiation, endocrine disorders, hormone levels change and genetic factors, etc. The pathogenesis remains unclear due to its complexity. There are various treatment methods for chloasma, especially laser treatment, whose accuracy and selectivity are reported to be excellent. Here the authors review relevant research of laser treatment in chloasma.

[1]
冯安吉,海春旭. 黄褐斑病因及发病机制 [J]. 第一军医大学学报, 2000, 20(2): 183-184.
[2]
李娟,颜敏,张媛, 等. 黄褐斑病因、发病机制及治疗进展 [J]. 中国麻风皮肤病杂志, 2016, 32(2): 123-126.
[3]
Lee BW, Schwartz RA, Janniger CK. Melasma [J]. G Ital Dermatol Venereol, 2016, Epub ahead of print.
[4]
Yalamanchili R, Shastry V, Betkerur J. Clinico-epidemilolgical Study and Quality of life Assessment in Melasma [J]. Indian J Dermatol, 2015, 60(5): 519.
[5]
Adalatkhah H, Sadeghi-Bazrgani H. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial [J]. Drug Des Devel Ther. 2015, 9: 4219-4225.
[6]
叶世龙. 黄褐斑病因机制研究 [J]. 中华中医药杂志, 2014, 29(12): 3806-3808.
[7]
丁徐安,袁定芳. 光学治疗黄褐斑的研究进展 [J]. 应用激光 2008, 28(2): 174-176.
[8]
Pallavi G, Gupta KL, Shreevathsa M, et al. Clinical evaluation of Varnya Gana Lepa in Vyanga(melasma) [J]. Ayu, 2015, 36(2): 151-156.
[9]
汤楠,吴艳华,李其林, 等. 黄褐斑病因及发病机制研究现状 [J]. 皮肤性病诊疗学杂志, 2013, 20(4): 302-304.
[10]
Hasegawa K, Fujiwara R, Sata K, et al. Possible Involvement of Keratinocyte Growth Factor in the Persistence of Hyperpigmentation in both Human Facial Solar Lentigines and Melasma [J]. Ann Dermatol, 2015, 27(5): 626-629.
[11]
Lima Ede A. Microneedling in facial recalcitrant melasma: report of a series of 22 cases [J]. An Bras Dermatol, 2015, 90(6): 919-921.
[12]
Kwon SH, Hwang YJ, Lee SK, et al. Heterogeneous Pathology of Melasma and Its Clinical Implications [J]. Int Mol Sci, 2016, 17(6). pii: E824.
[13]
Wu DC, Fitzpatrick RE, Goldman MP. Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma [J]. J Clin Aesthet Dermatol, 2016, 9(2): 48-57.
[14]
Lee HC, Thng TG, Goh CL. Oral tranexamic acid(TA)in the treatment of melasma: A retrospective analysis [J]. Academic Journal, 2016, 75(2): 385-393.
[15]
Yun WJ, Lee SM, Han JS, et al. A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians [J]. J Cosment Laser Ther, 2015, 17(5): 259-266.
[16]
宋群先. 冯宪章教授治疗黄褐斑经验 [J]. 中医研究, 2015, 28(5): 48-49.
[17]
Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation [J]. Science, 1983, 220: 524-527.
[18]
肖学敏,谭军,李高峰. 黄褐斑激光治疗进展 [J]. 现代医药卫生, 2011, 27(2): 242-244.
[19]
Polder KD, Landau JM, Vergilis-Kalner IL, et al. Laser eradication of pigmentation lesions: a review [J]. Dermatol Surg, 2011, 37: 572-595.
[20]
Hilton S, Heise H, Buhren BA, et al. Treatment of melasma in Caucasian patients using a novel 694nm Q-Switched ruby fractional laser [J]. Eur J Med Res, 2013, 18(1): 43.
[21]
Wanner M, Sakamoto FH, Avram MM, et al. Immediate Skin responses to laser and light treatments: Warning endpoints: How to avoid side effects [J]. J Am Acad Dermatol, 2016, 74(5): 807-819.
[22]
Arora P, Sarkar R, Garg VK, et al. Laser for treatment of melasma and post-inflammatory hyperpigmentation [J]. J Cutan Aesthet Surg, 2012, 5(2): 93-103.
[23]
Bae MI, Park JM, Jeony KH, et al. Effectiveness of low-fluence and short-pulse intense pulsed llight in the treatment of melasma: A randomized study [J]. J Cosment Laser Ther, 2015, 17(6): 292-295.
[24]
Ball Arefiev KL, Hantash BM. Advance in the treatment of melasma: a review of the recent literature [J]. Dermatol Surg, 2012, 38: 971-984.
[25]
Wong Y, Lee SS, Goh CL. Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot- Size QS Nd: YAG Laser Treatments [J]. Ann Dermatol, 2015, 27(6): 751-755.
[26]
Yue B, Yang Q, Xu J, et al. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients [J]. Lasers Med Sci, 2016, 31(8): 1657-1663.
[27]
Kim JY, Choi M, Nam CH, et al. Treatment of Melasma with the Photoacoustic Twin Pulse M ode of Low-Fluence 1, 064nm Q-Switched Nd: YAG Laser [J]. Ann Dermatol, 2016, 28(3): 290-296.
[28]
Jalaly NY, Valizadeh N, Barikbin B, et al. Low-power fractional CO2 laser versus low-fluence Q-Switched 1, 064nm Nd: YAG laser for treatment of melasma: a randomized, controlled, split-face study [J]. Am J Chi Dermatol, 2014, 15(4): 357-363.
[29]
Baleg SM, Bidin N, Suan LP, et al. The effect of CO2 laser treatment on skin tissue [J]. J Cosmet Dermatol, 2015, 14(3): 246-253.
[30]
鲍琳琳,李远红. 1550nm点阵激光与红宝石激光治疗黄褐斑疗效对比 [J]. 实用皮肤病学杂志, 2015, 8(6): 453-456.
[31]
Na SY, Cho S, Lee JH, et al. Intense Pulsed Light and Low-Fluence Q-Switched Nd: YAG Laser Treatment in Melasma Patients [J]. Ann Dermatol, 2012, 24(3): 267-273.
[32]
Tong LG, Wu Y, Wang B, et al. Combination of fractional QSRL and IPL for melasma treatment in Chinese population [J]. J Cosmet Laser Ther, 2017, 19(1): 13-17.
[33]
Tian WC. Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er: YAG and 1064-nm Q-Switched Nd: YAG laser [J]. J Cosmet Laser Ther, 2016, 18(2): 72-74.
[1] 李欣, 魏艺, 张娟, 张娟娟, 凌秀凤, 赵纯, 张媔秋. 高龄女性冻胚移植周期临床妊娠结局的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 276-283.
[2] 夏婷君, 段耀祥, 段霞, 刘金凤. 助产士共情疲劳现状及影响因素研究[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 302-311.
[3] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[4] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[5] 陈文进, 张月君, 王传泰. 腹腔镜远端胃癌根治术后肠梗阻发生的影响因素研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 389-392.
[6] 兰华, 高丽莎, 申明, 张铭光. 内镜黏膜下剥离术后溃疡出血的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 467-469.
[7] 孙红燕, 李娟. 造口旁疝患者生活质量的影响因素分析[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 273-276.
[8] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[9] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[10] 房桂彬, 肖进, 傅光涛, 郑秋坚. 老年髋部骨折患者术后1年行走能力的影响因素分析[J]. 中华老年骨科与康复电子杂志, 2024, 10(05): 273-280.
[11] 单良, 刘怡, 于涛, 徐丽. 老年股骨颈骨折术后患者心理弹性现状及影响因素分析[J]. 中华老年骨科与康复电子杂志, 2024, 10(05): 294-300.
[12] 陶金华, 陈珊珊, 陈晓四. 阿帕替尼联合替吉奥治疗晚期食管癌的疗效与安全性影响因素评价[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 325-329.
[13] 孙伟, 刘敬峰, 陈晨, 杨磊. 奥沙利铂联合卡培他滨新辅助化疗治疗局部进展期低位直肠癌的疗效及影响因素[J]. 中华消化病与影像杂志(电子版), 2024, 14(03): 208-212.
[14] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15] 彭小蓉, 莫伟, 李琴, 吴雅琴, 李兰. 妊娠期妇女静脉血栓栓塞症预防的知信行现状及其影响因素分析[J]. 中华介入放射学电子杂志, 2024, 12(03): 274-280.
阅读次数
全文


摘要